DACTINOMYCIN

Generic: DACTINOMYCIN

Meitheal Pharmaceuticals Inc.Manufacturer
INTRAVENOUSRoute
DACTINOMYCINActive Substance
2020-11-13Original Approval

DACTINOMYCIN is FDA application ANDA213463, sponsored by MEITHEAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
OFF LABEL USE
282 reports
2
FEBRILE NEUTROPENIA
197 reports
3
PRODUCT USE IN UNAPPROVED INDICATION
133 reports
4
NEUTROPENIA
127 reports
5
DRUG INEFFECTIVE
117 reports
6
THROMBOCYTOPENIA
106 reports
7
VOMITING
105 reports
8
PYREXIA
93 reports
9
ANAEMIA
89 reports
10
DISEASE PROGRESSION
86 reports